Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 3;14(11):e039185.
doi: 10.1161/JAHA.124.039185. Epub 2025 May 23.

Association of Differences in Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate With Prevalence and Incidence of Stroke

Affiliations

Association of Differences in Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate With Prevalence and Incidence of Stroke

Xiaohua Shi et al. J Am Heart Assoc. .

Abstract

Background: The intraindividual difference between the estimated glomerular filtration rates by cystatin C and creatinine (ie, eGFRdiff) is of clinical importance. This study aimed to investigate the cross-sectional and longitudinal associations of eGFRdiff with stroke using nationally representative data from the CHARLS (China Health and Retirement Longitudinal Study).

Methods: This study included 11 869 participants (aged ≥45 years) from the CHARLS 2015 for the cross-sectional analysis. A total of 11 553 participants free of stroke were recruited in 2015 as baseline and followed up to 2020 for the cohort analysis. The eGFRdiff was calculated by subtracting estimated glomerular filtration rate by serum creatinine from estimated glomerular filtration rate by serum cystatin C at baseline. Logistic regression models and Cox proportional hazards models were used to examine the cross-sectional and longitudinal associations.

Results: The mean age of the participants was 60.3±9.6 years, and 5514 (46.5%) were men. According to the cross-sectional analysis, a negative eGFRdiff was associated with a greater prevalence of stroke (odds ratio per 1 SD, 0.841 [95% CI, 0.741-0.955]). During a median follow-up of 5.0 years, 838 individuals (7.3%) experienced incident stroke. A lower baseline eGFRdiff was associated with a greater risk of stroke onset (hazard ratio [HR] per 1 SD, 0.884 [95% CI, 0.817-0.955]). Compared with those in the midrange eGFRdiff group (from -15 to 15 mL/min per 1.73 m2), those in the negative eGFRdiff group (<-15 mL/min per 1.73 m2) exhibited a significantly increased risk of incident stroke (HR, 1.202 [95% CI, 1.026-1.407]).

Conclusions: A large negative eGFRdiff was independently associated with higher prevalence and incidence rates of stroke among middle-aged and older Chinese adults.

Keywords: creatinine; cystatin C; eGFRdiff; estimated glomerular filtration rate; stroke.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flowchart for participant inclusion and follow‐up in the study.
Figure 2
Figure 2. Correlations between the eGFRdiff and other factors.
A, Spearman coefficients of eGFRdiff. B, Proportions of eGFRdiff groups stratified by eGFRcr levels. C, Proportions of eGFRdiff groups stratified by BMI levels. D, Proportions of eGFRdiff groups stratified by age groups. E, Proportions of eGFRdiff groups stratified by sex. BMI indicates body mass index; eGFR, estimated glomerular filtration rate, eGFRcr, eGFR by serum creatinine, eGFRcys, eGFR by serum cystatin C; eGFRdiff, differences in eGFRcys and eGFRcr.
Figure 3
Figure 3. Restricted cubic spline analysis for the association between the baseline eGFRdiff and the risk of stroke in cross‐sectional and cohort analyses.
eGFRdiff indicates the difference between cystatin C and creatinine‐based estimated glomerular filtration rate levels.
Figure 4
Figure 4. Cumulative incidence rates of stroke by baseline eGFRdiff.
Midrange = eGFRdiff: −15 to 15 mL/min per 1.73 m2, negative = eGFRdiff: <−15 mL/min per 1.73 m2, and positive = eGFRdiff: >15 mL/min per 1.73 m2. eGFRdiff indicates the difference between cystatin C and creatinine‐based estimated glomerular filtration rate levels.

References

    1. Saini V, Guada L, Yavagal DR. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology. 2021;97:S6–s16. doi: 10.1212/wnl.0000000000012781 - DOI - PubMed
    1. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, et al; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010); GBD Stroke Experts Group . Global and regional burden of stroke during 1990‐2010: findings from the global burden of disease study 2010. Lancet. 2014;. 383: 245‐254. doi: 10.1016/s0140-6736(13)61953-4 24449944 - DOI - PMC - PubMed
    1. Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, Fisher M, Pandian J, Lindsay P. World stroke organization (WSO): global stroke fact sheet 2022. Int J Stroke. 2022;17:18–29. doi: 10.1177/17474930211065917 - DOI - PubMed
    1. Tu WJ, Zhao Z, Yin P, Cao L, Zeng J, Chen H, Fan D, Fang Q, Gao P, Gu Y, et al. Estimated burden of stroke in China in 2020. JAMA Netw Open. 2023;6:e231455. doi: 10.1001/jamanetworkopen.2023.1455 - DOI - PMC - PubMed
    1. O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao‐Melacini P, Zhang X, Pais P, Agapay S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case‐control study. Lancet. 2016;388:761–775. doi: 10.1016/s0140-6736(16)30506-2 - DOI - PubMed

LinkOut - more resources